EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models

Diana C Márquez-Garbán iD, Cristian D Yanes, Gabriela Llarena, David Elashoff, Nalo Hamilton iD, Mary Hardy, Madhuri Wadehra iD, Susan A McCloskey, Richard J Pietras iD

Nutrients · 2024

DOI: 10.3390/nu16142369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Diana C Márquez-Garbán und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Honey, Breast Neoplasms, Apoptosis, Cell Proliferation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hickey Family Foundation, California Breast Cancer Research Program, UCLA Jonsson Comprehensive Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0% (w/v) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF-7 cells, but anti-proliferative effects of MH were less pronounced in MDA-MB-231 breast cancer cells. Effects of MH were also tested on non-malignant human mammary epithelial cells (HMECs) at 2.5% w/v, and it was found that MH reduced the proliferation of MCF-7 cells but not that of HMECs. Notably, the antitumor activity of MH was in the range of that exerted by treatment of MCF-7 cells with the antiestrogen tamoxifen. Further, MH treatment stimulated apoptosis of MCF-7 cells in vitro, with most cells exhibiting acute and significant levels of apoptosis that correlated with PARP activation. Additionally, the effects of MH induced the activation of AMPK and inhibition of AKT/mTOR downstream signaling. Treatment of MCF7 cells with increased concentrations of MH induced AMPK phosphorylation in a dose-dependent manner that was accompanied by inhibition of phosphorylation of AKT and mTOR downstream effector protein S6. In addition, MH reduced phosphorylated STAT3 levels in vitro, which may correlate with MH and AMPK-mediated anti-inflammatory properties. Further, in vivo, MH administered alone significantly inhibited the growth of established MCF-7 tumors in nude mice by 84%, resulting in an observable reduction in tumor volume. Our findings highlight the need for further research into the use of natural compounds, such as MH, for antitumor efficacy and potential chemoprevention and investigation of molecular pathways underlying these actions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HoneyBreast NeoplasmsApoptosisCell ProliferationHumansFemaleAnimalsMCF-7 CellsSignal TransductionMiceXenograft Model Antitumor AssaysMice, NudeLeptospermumTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktAntineoplastic AgentsSTAT3 Transcription FactorDisease ProgressionAMP-Activated Protein KinasesCell Line, TumorPhosphorylation

Stichwörter der Autor:innen

AMP kinase signalingManuka honeySTAT3breast cancerestrogen receptor-positive breast cancerin vivo xenograftsmTORtriple-negative breast cancer

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktAntineoplastic AgentsSTAT3 Transcription FactorAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.
  • Division of General Internal Medicine, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • School of Nursing, UCLA, Los Angeles, CA 90095, USA.
  • Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.
  • Department of Radiation Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA.

ORCID-Profile: Diana C Márquez-Garbán, Nalo Hamilton, Madhuri Wadehra, Richard J Pietras

Förderung

  • Hickey Family Foundation
  • California Breast Cancer Research Program
  • UCLA Jonsson Comprehensive Cancer Center
  • NCI NIH HHS
  • Manuka Health NZ Ltd.
  • Jonsson Comprehensive Cancer Center Breast Cancer Award
  • Hickey Foundation
  • Integrative Oncology

Zitieren

APA

Márquez-Garbán, D. C., Yanes, C. D., Llarena, G., Elashoff, D., Hamilton, N., Hardy, M., Wadehra, M., McCloskey, S. A., & Pietras, R. J. (2024). Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients. https://doi.org/10.3390/nu16142369

Vancouver

Márquez-Garbán DC, Yanes CD, Llarena G, Elashoff D, Hamilton N, Hardy M, et al. Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients. 2024. doi:10.3390/nu16142369

BibTeX
@article{MrquezGarbn2024,
  author = {Márquez-Garbán, Diana C and Yanes, Cristian D and Llarena, Gabriela and Elashoff, David and Hamilton, Nalo and Hardy, Mary and Wadehra, Madhuri and McCloskey, Susan A and Pietras, Richard J},
  title = {Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16142369}
}
Kostenlos starten →